Champions Oncology (CSBR) Cash from Investing Activities Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) Cash from Investing Activities Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Champions Oncology |
81.79 Mn |
74.79 Mn |
13.89 Mn |
73.52% |
| Date | Value |
|---|
| Jan 31, 2026 |
73.52% |
| Oct 31, 2025 |
26.28% |
| Jul 31, 2025 |
60.63% |
| Apr 30, 2025 |
20.63% |
| Jan 31, 2025 |
53.02% |
| Oct 31, 2024 |
45.03% |
| Apr 30, 2024 |
26.07% |
| Jan 31, 2024 |
57.55% |
| Oct 31, 2023 |
46.15% |
| Jul 31, 2023 |
-2.19% |
| Apr 30, 2023 |
20.75% |
| Jan 31, 2023 |
-63.98% |
| Oct 31, 2022 |
-67.04% |
| Jul 31, 2022 |
-0.22% |
| Apr 30, 2022 |
-53.10% |
| Jan 31, 2022 |
-25.07% |
| Oct 31, 2021 |
-27.20% |
| Jul 31, 2021 |
-62.60% |
| Apr 30, 2021 |
-58.61% |
| Jan 31, 2021 |
-152.19% |
